Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Tiffany J. Rios-Fuller, Gabriela Ortiz-Soto, Mercedes Lacourt-Ventura, Gerónimo Maldonado-Martinez, Luis A. Cubano, Robert J. Schneider, Michelle M. Martinez-Montemayor
Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35907-35921
Joelle N. Zambrano, Christina J. Williams, Carly Bess Williams, Lonzie Hedgepeth, Pieter Burger, Tinslee Dilday, Scott T. Eblen, Kent Armeson, Elizabeth G. Hill, Elizabeth S. Yeh
Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35962-35973
Markus Friedemann, Brit Nacke, Albert Hagelgans, Carsten Jandeck, Nicole Bechmann, Martin Ullrich, Birgit Belter, Christin Neuber, Olga Sukocheva, Jens Pietzsch, Mario Menschikowski
Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35983-35996
Vickie A. Marshall, Nazzarena Labo, Joanna Sztuba-Solinska, Elena M. Cornejo-Castro, Karen Aleman, Kathleen M. Wyvill, Lynne McNamara, Stuart F.J. Le Grice, Robert Yarchoan, Thomas S. Uldrick, Patrick MacPhail, Mark N. Polizzotto, Denise Whitby
Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35856-35869